Wilmot EG - Search Results

1

Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.

Leelarathna L, Evans ML, Neupane S, Rayman G, Lumley S, Cranston I, Narendran P, Barnard-Kelly K, Sutton CJ, Elliott RA, Taxiarchi VP, Gkountouras G, Burns M, Mubita W, Kanumilli N, Camm M, Thabit H, Wilmot EG; FLASH-UK Trial Study Group. Leelarathna L, et al. Among authors: wilmot eg. N Engl J Med. 2022 Oct 20;387(16):1477-1487. doi: 10.1056/NEJMoa2205650. Epub 2022 Oct 5. N Engl J Med. 2022. PMID: 36198143 Clinical Trial.

2

External validation of two diabetes risk scores in a young UK South Asian population.

Gray LJ, Khunti K, Wilmot EG, Yates T, Davies MJ. Gray LJ, et al. Among authors: wilmot eg. Diabetes Res Clin Pract. 2014 Jun;104(3):451-8. doi: 10.1016/j.diabres.2014.03.018. Epub 2014 Apr 2. Diabetes Res Clin Pract. 2014. PMID: 24785738

3

Diabetes and pregnancy.

Wilmot EG, Mansell P. Wilmot EG, et al. Clin Med (Lond). 2014 Dec;14(6):677-80. doi: 10.7861/clinmedicine.14-6-677. Clin Med (Lond). 2014. PMID: 25468858 Free PMC article.

4

Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control.

Anyanwagu U, Olaoye H, Jennings P, Ashton-Cleary S, Sugunendran S, Hughes D, Idris I, Wilmot EG. Anyanwagu U, et al. Among authors: wilmot eg. Diabet Med. 2017 Aug;34(8):1154-1157. doi: 10.1111/dme.13367. Epub 2017 May 16. Diabet Med. 2017. PMID: 28430381

5

Flash forward: a review of flash glucose monitoring.

Leelarathna L, Wilmot EG. Leelarathna L, et al. Among authors: wilmot eg. Diabet Med. 2018 Apr;35(4):472-482. doi: 10.1111/dme.13584. Epub 2018 Feb 27. Diabet Med. 2018. PMID: 29356072 Review.

6

Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice.

Ajjan RA, Cummings MH, Jennings P, Leelarathna L, Rayman G, Wilmot EG. Ajjan RA, et al. Among authors: wilmot eg. Diab Vasc Dis Res. 2018 May;15(3):175-184. doi: 10.1177/1479164118756240. Epub 2018 Feb 15. Diab Vasc Dis Res. 2018. PMID: 29446646 Free article. Review.

7

Reply to Argento. Flash forward, with caution.

Leelarathna L, Wilmot EG. Leelarathna L, et al. Among authors: wilmot eg. Diabet Med. 2018 Aug;35(8):1132-1134. doi: 10.1111/dme.13655. Diabet Med. 2018. PMID: 29687494 No abstract available.

8

Language matters. Addressing the use of language in the care of people with diabetes: position statement of the English Advisory Group.

Cooper A, Kanumilli N, Hill J, Holt RIG, Howarth D, Lloyd CE, Kar P, Nagi D, Naik S, Nash J, Nelson H, Owen K, Swindell B, Walker R, Whicher C, Wilmot E. Cooper A, et al. Diabet Med. 2018 Dec;35(12):1630-1634. doi: 10.1111/dme.13705. Diabet Med. 2018. PMID: 29888553

9

Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.

Perera R, Oliver N, Wilmot E, Marriott C. Perera R, et al. Diabet Med. 2018 Nov;35(11):1617-1618. doi: 10.1111/dme.13766. Diabet Med. 2018. PMID: 29931731 No abstract available.

10

Language matters: a UK perspective.

Lloyd CE, Wilson A, Holt RIG, Whicher C, Kar P; Language Matters Group. Lloyd CE, et al. Diabet Med. 2018 Dec;35(12):1635-1641. doi: 10.1111/dme.13801. Diabet Med. 2018. PMID: 30103276 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page